Serpin inhibitors for the treatment of prion and prion like diseases

Summary:

A research group based in Italy has developed a new class of small molecules acting as SERPINA3 inhibitors, which are able to reduce prion protein (PrPSc) accumulation in prion-infected cell lines, thereby representing a new therapeutic treatment against prion and prion-like diseases. They are looking for licence agreements and joint venture agreements with pharma companies and/or financial agreements with investors.

Reference: TOIT20210421001

Country: Italy

Submitted: 6. 11. 2021

View Partnering Opportunity

Keywords

Technology: Neurology, Brain Research.

Market: Drug delivery and other equipment.

NACE: -

Technologické nabídky a poptávky zpracovává BIC Plzeň, partner sítě Enterprise Europe Network.